Avricore Health AVCRF
OTC AVCRF
$0.03 +0.00 (+0.00%)
At close: Aug 25, 2026 · 4:00 PM EDT

Avricore Health (AVCRF) Operating Leases (2019)

Avricore Health (AVCRF) posted quarterly Operating Leases of $16202.9 for Q4 2019.

Avricore Health (AVCRF) Operating Leases (2019) Analysis & Trends

Avricore Health (AVCRF) has reported Operating Leases for 1 consecutive years, with $16202.9 the latest figure, recorded in Q4 2019.

  • In Q4 2019, Operating Leases changed N/A year-over-year to $16202.9; the TTM figure through Dec 2019 stood at $16202.9 (changed N/A YoY), while the FY2019 annual figure was $16121.2, changed N/A from the prior year.
  • Operating Leases was little changed at $16202.9 in Q4 2019 per AVCRF's latest filing.
  • Across five years, Operating Leases topped out at $16202.9 in Q4 2019 and bottomed at $16202.9 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Avricore Health 3.04 Mn 3.01 Mn -6.20 Bn

Historic Data

Download Data
DateValue
Dec 31, 2019 16,202.89